Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-26

Clinical Trial Update: Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine [Phase 2]

View source ↗

Summary

Phase 2 rollover trial protocol in pediatric patients in South Africa for continued access to Emtricitabine in HIV-1 infection, with trial results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Emtricitabine (Emtricitabine)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2018-04-26